The short answer is: a little, for some things, far less than the marketing implies, and not in the way you are being sold. "Nature's Ozempic" is a phrase that should make you close the tab. But dismissing the whole category is also wrong — a couple of the mechanisms are real, and one group of these products solves a genuine problem. Here is the honest version.
The scale of the gap
- •Semaglutide produces roughly 15% average body weight reduction in phase 3 trials. Tirzepatide reaches around 21% at the highest dose.
- •No GLP-1 supplement has produced anything remotely comparable in a controlled trial. Most have no weight-outcome trial at all.
- •These are different mechanisms. A drug activates the receptor. A supplement at best nudges how much of your own hormone you secrete.
Why a receptor agonist isn't comparable to a booster
Your gut secretes GLP-1 naturally after you eat. It is a satiety and blood sugar hormone, and it is broken down within minutes by an enzyme called DPP-4. That short half-life is the whole reason natural GLP-1 doesn't control appetite the way the drugs do.
Semaglutide is engineered specifically to defeat that. It resists DPP-4 degradation and binds albumin, which extends its half-life to about a week. One injection holds the receptor active continuously for days.
A fibre supplement might produce a transient rise in your own GLP-1 after a meal, lasting minutes to hours, at a fraction of the concentration. Both technically involve GLP-1. Calling them equivalent is like calling a candle and a floodlight both "light sources".
What actually has evidence
Fermentable fibre. This is the most defensible mechanism in the category and it isn't controversial. Fibre reaching the colon undigested gets fermented into short-chain fatty acids, which stimulate GLP-1 secretion from intestinal L-cells. Most people eat around 15 grams of fibre a day against a recommended 25 to 30, so there is a real gap to close. Expect better satiety and regularity — not dramatic weight loss.
Akkermansia muciniphila. The one probiotic strain here with a randomised human trial behind it. Three months of supplementation in overweight, insulin-resistant adults improved insulin sensitivity and markers of liver dysfunction and inflammation versus placebo, published in Nature Medicine. Effects on body weight were modest. Note that the studied form was pasteurised, a detail most consumer products gloss over.
Berberine. The ingredient most responsible for the "nature's Ozempic" label. It does have real effects on glucose metabolism — studies comparing it to metformin exist. But it is not a GLP-1 agonist, the weight effects are small, and it has meaningful drug interactions. It deserves neither the hype nor complete dismissal.
What has thin or no evidence
Most botanical "GLP-1 support" blends — combinations of green tea extract, yerba mate, ginseng, turmeric and similar — rest on small studies with surrogate endpoints, not weight outcomes. A physician review of one leading branded product concluded it may have small effects on snacking and blood sugar but likely no reliable weight loss effect.
Apple cider vinegar gummies, capsaicin thermogenics and most proprietary blends fall into the same bucket. Not dangerous. Just not doing what the packaging implies.
The category that genuinely works
Companion supplements — the ones taken alongside a prescription GLP-1 rather than instead of one — rest on much firmer ground, because the problem they solve is arithmetic rather than hormonal.
If a medication cuts your food intake substantially, your protein and micronutrient intake falls with it. That isn't a hypothesis. And it matters: roughly a quarter to a third of weight lost on GLP-1 therapy is lean tissue, and inadequate protein is the main modifiable driver of that ratio.
A protein shake for someone on Zepbound who can't face solid food is doing real, measurable work. It is the least glamorous corner of this market and the one where the money is best spent.
How to shop this category without getting fleeced
- Treat "nature's Ozempic" as a red flag. It signals a company willing to imply something it cannot support.
- Check for a proprietary blend. If per-ingredient doses aren't disclosed, you can't compare them to anything studied.
- Compare the dose to the research. Psyllium studies use grams; a capsule holds a fraction of one. Format matters.
- Price it over six months. These products work gradually if at all, so the sustainable monthly cost matters more than a launch discount.
- Look for third-party testing. Supplements have no FDA pre-approval, so voluntary disclosure is the only quality signal you get.
Bottom line
Fibre and Akkermansia have real, modest evidence for metabolic and gut health. Companion supplements solve a genuine nutritional problem for people already on medication. Everything else in this category is priced well ahead of what it can demonstrate. If you want the effect the medications produce, you need the medications.
See our ranked GLP-1 supplement comparison for what we'd actually buy.